Entrada Therapeutics, Inc. (TRDA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2020: -$26.67M2021: -$51.13M2022: -$97.25M2023: -$3.16M2024: $47.01M2025: -$157.90M-$157.90M
2020Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$157.90M-435.9%
2024$47.01M+1586.7%
2023-$3.16M+96.7%
2022-$97.25M-90.2%
2021-$51.13M-91.7%
2020-$26.67M